JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, M. V.
Right arrow Articles by Downey, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, M. V.
Right arrow Articles by Downey, J. M.

J Thorac Cardiovasc Surg 1997;114:236-242
© 1997 Mosby, Inc.


CARDIOPULMONARY BYPASS,
MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

INTRAVENOUS CO-INFUSION OF ADENOSINE AND NOREPINEPHRINE PRECONDITIONS THE HEART WITHOUT ADVERSE HEMODYNAMIC EFFECTS

Michael V. Cohen, MD, Jon D. Thornton, MD, PhD, Christy S. Thornton, MD, Hiroshi Sato, PhD, Takayuki Miki, MD, James M. Downey, PhD, From the Departments of Medicine and Physiology, University of South Alabama College of Medicine, Mobile, Ala.

Supported in part by grants from the National Institutes of Health: Heart, Lung, and Blood Institute grants HL-20648 and HL-50688.

Received for publication Dec. 16, 1996 Revisions requested Feb. 14, 1997; revisions received March 11, 1997 Accepted for publication March 13, 1997. Address for reprints: Michael V. Cohen, MD, Department of Physiology, MSB 3050, University of South Alabama, College of Medicine, Mobile, AL 36688.

Abstract

Objective: A simple intervention is needed that could protect the heart against infarction during limited-access coronary artery bypass grafting. Adenosine and norepinephrine can precondition the heart with resulting protection, but adverse hemodynamic effects prevent clinical application. Because heart rate, blood pressure, and contractility effects of these two drugs are diametrically opposite, a mixture might be beneficial. Methods:  A superficial branch of the left coronary artery of rabbits was surrounded with a suture. Infarction was produced in all hearts by a 30-minute coronary artery occlusion. Infarct size after reperfusion was measured and is presented as a percentage of the risk zone. The effect of 5-minute intravenous co-infusion of adenosine (20 mg/kg) and norepinephrine (0.1 mg/kg) 15 minutes before ischemia was examined. In addition, the protective effect of three sequential intravenous bolus injections of adenosine at either 0.2 or 0.4 mg/kg was evaluated. Results:  Thirty minutes of regional ischemia caused infarction of 40% ± 4% of the risk zone. The combination of adenosine and norepinephrine caused no change in blood pressure but rather protected the heart, with infarction of only 9% ± 2% of the risk zone (p = 0.0001 vs control). Adenosine-norepinephrine co-infusion still protected the heart when the interval between infusion and ischemia was extended to 60 minutes, but it did not protect with a 120-minute interval. Intravenous bolus injections of adenosine resulted in cardiac slowing and marked hypotension. Boluses of 0.2 mg/kg resulted in a minimal, but significant, reduction in infarct size, whereas the higher dose provided no protection. Conclusion: Adenosine-norepinephrine co-infusion provides a feasible and safe parenteral method for preconditioning the heart. J Thorac Cardiovasc Surg 1997;114:236-42




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
I. Ahmet, Y. Sawa, M. Nishimura, T. Yamaguchi, M. Kitakaze, and H. Matsuda
Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning
Ann. Thorac. Surg., September 1, 2000; 70(3): 901 - 905.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. E. Saltman, I. B. Krukenkamp, G. R. Gaudette, H. Horimoto, and S. Levitsky
Pharmacological preconditioning with the adenosine triphosphate-sensitive potassium channel opener pinacidil
Ann. Thorac. Surg., August 1, 2000; 70(2): 595 - 601.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
W. E. Johnston
Preconditioning the Brain and Heart: Implications for Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. D. McCully, M. Uematsu, and S. Levitsky
Adenosine-enhanced ischemic preconditioning provides myocardial protection equal to that of cold blood cardioplegia
Ann. Thorac. Surg., March 1, 1999; 67(3): 699 - 704.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Uematsu, G. R. Gaudette, J. O. Laurikka, S. Levitsky, and J. D. McCully
Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart
Ann. Thorac. Surg., August 1, 1998; 66(2): 382 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. A. Kloner and G. Kay
EDITORIAL: INTRAVENOUS CO-INFUSION OF ADENOSINE AND NOREPINEPHRINE
J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 234 - 235.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The American Association for Thoracic Surgery.